LYTIR

Company · VNDA

Vanda Pharmaceuticals Inc.

Nasdaq's symbol directory lists VNDA on Nasdaq as “Vanda Pharmaceuticals Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($38K); 4 filings by holders of 5% or more.

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Charles Cliff Duncan bought on 3 days latest Nov 5, 2026 bought $38K
Every trade (3)
  1. BUYCharles Cliff Duncan bought Nov 5, 2026 5,803 shares filing $22K
  2. BUYCharles Cliff Duncan bought Nov 4, 2026 3,447 shares filing $13K
  3. BUYCharles Cliff Duncan bought Nov 3, 2026 750 shares filing $3K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. BlackRock Portfolio Management LLC filed Oct 27, 2026 Schedule 13G passive 3,587,013 shares filing 5.9%
  2. Millennium Management LLC filed Oct 9, 2026 Schedule 13G/A passive filing 7%
  3. Millennium Management LLC filed Aug 19, 2026 Schedule 13G passive filing 5.6%
  4. AQR Capital Management, LLC filed Aug 13, 2026 Schedule 13G passive 3,497,695 shares filing 5.82%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.